SNY wins Japan orphan drug tag for Waylirz in IgG4-RD and adds regulatory perks as the BTK inhibitor advances in late-stage studies.

Real-world evidence shows Pluvicto matches pivotal trial benefits in PSMA-positive mCRPC, with longer PFS after one ARPI and delayed chemotherapy.

Bloom Energy is rated Hold, positioned as a critical enabler for AI infrastructure with its native 800V DC, battery-less, ...

Many said Priyanka's acting and dialogue delivery looked as if she were rehearsing a school play. Viewers believe the actress ...

Radio spectrum is pricey. Operators drop billions at auction to lock down licensed frequency bands, and every single frequency counts. Dynamic Spectrum Sharing (DSS) was built to address exactly this, ...

I sort of hoped Brain.fm was selling snake oil, but I liked it more than I expected to.

T cells are highly adaptable white blood cells that protect us from infections, cancer, and other threats. To do their job, T cells must rapidly switch from a quiet resting state to an active, energy ...

The evidence is solid but not definitive, as the conclusions rely on the absence of changes in spatial breadth and would benefit from clearer statistical justification and a more cautious ...

The Phase 1 study is a randomized, double-blind, placebo-controlled, dose-escalation trial carried out in China, designed to evaluate the safety, tolerability, pharmacokinetics (PK), and ...

Boehringer Ingelheim acquires an exclusive license for a preclinical oral immunology program from Sitryx in a deal worth over ...

Sanofi’s rilzabrutinib earns orphan drug designation in Japan for IgG4-related disease Designation based on positive data from a phase 2 study of ...

While AI has advanced in perception and reasoning, the physical challenge remains: teaching a machine how to move with ...